This prospective study will include both an intervention and control arm. The control arm will receive face-to-face pharmacy clinic visits per standard of care. The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up. Patients with a hemoglobin A1c in the last 3 months greater than 9% will be eligible. Eligible patients must have a primary care physician at Johns Hopkins Outpatient Center (JHOC) or East Baltimore Medical Center (EBMC).

Purpose: To compare the change in hemoglobin A1c over the 3 month study period in the intervention group in which patients participate in telemedicine, to a control group in which they do not

Inclusion Criteria:

• Adult patients with a primary care provider at JHOC or EMBC
• Patients have seen primary care provider within last 6 months
• Patients with hemoglobin A1c greater than 9%

Exclusion Criteria:

• Patients <18 years of age
• Patients with previously established care with JHH ambulatory care pharmacist
• Patients with communication barriers who do not have a caregiver
• Patients with new diagnosis of diabetes
• Patients who are pregnant or planning to become pregnant during the time of the study
• Patients followed by Endocrinology or Diabetes Center